In vitro, BMS-387032 inhibits Cdk2 phosphorylation in the A2780 ovarian carcinoma cell line, inhibiting the phosphorylation of downstream targets of Cdk2 including pRb, histone H1 and DNA polymerase-α. The gene discussed is CDK2; the disease is ovarian carcinoma.